New insight into myocardin regulation and function in smooth muscle cells
(2023) In Lund University, Faculty of Medicine Doctoral Dissertation Series- Abstract
- Smooth muscle cells (SMCs) are constituents of hollow inner organs. Their contractile function governs essential physiological functions, such as breathing, eating, blood pressure control, urination, and childbirth. Skeletal and cardiac muscle cells are terminally differentiated cell types, but SMCs are highly plastic and change their phenotype in disease. Cues presented by the microenvironment and altered biomechanics result in phenotypic conversions of SMCs. In the classical paradigm, SMCs are considered to switch from a contractile phenotype to a synthetic phenotype in response to changes in the microenvironment. Myocardin and two closely related transcription factors (MRTF-A and MRTF-B) play an important role in controlling SMC... (More)
- Smooth muscle cells (SMCs) are constituents of hollow inner organs. Their contractile function governs essential physiological functions, such as breathing, eating, blood pressure control, urination, and childbirth. Skeletal and cardiac muscle cells are terminally differentiated cell types, but SMCs are highly plastic and change their phenotype in disease. Cues presented by the microenvironment and altered biomechanics result in phenotypic conversions of SMCs. In the classical paradigm, SMCs are considered to switch from a contractile phenotype to a synthetic phenotype in response to changes in the microenvironment. Myocardin and two closely related transcription factors (MRTF-A and MRTF-B) play an important role in controlling SMC phenotype, and myocardin is essential for differentiation of SMCs during development. MRTFs form a ternary complex with serum response factor (SRF) on so called CArG boxes located in promoters and introns of thousands of genes. This thesis aims to provide new insights into the transcriptional regulation of and by myocardin-related transcription factors in SMCs.
In my first study, I identified a previously undescribed transcriptional target of the MRTFs, namely the muscarinic M3 receptor, CHRM3. CHRM3 was activated by all MRTFs, but it was particularly forcefully regulated by MRTF-B. Knockout of SRF resulted in reduced CHRM3 expression in the urinary bladder and in the intestinal tract. In another study, I show that MRTFs cause cell type-dependent suppression of inflammation. This occurs partly through RelA titration and inhibition of NF-κB signaling. Hence, phenotypic modulation of SMCs involves toggling between contractile and inflammatory phenotypes, in addition to the classical switching between contractile and synthetic phenotypes. In a third study, I demonstrate that myocardin controls exon usage and splicing in SMCs and that this is mediated in part by RBPMS and RBFOX2. Among the splicing targets is myocardin itself, which may allow for slow and splicing-dependent SMC maturation. Finally, by studying mice with conditional and SMC-specific knockout of YAP and TAZ, I demonstrate reduction of myocardin expression in the urinary bladder. This has consequences for contractile differentiation, expression of muscarinic receptors, gene splicing, and contractility of bladder SMCs.
In summary, new insight into transcriptional regulation of and by MRTFs in SMCs is provided by the papers in this thesis. This insight has stimulated ideas for treating disease and reducing side effects of available therapies. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/16288e5b-36fa-4770-8683-0b56c4298309
- author
- Liu, Li LU
- supervisor
-
- Karl Swärd LU
- Catarina Rippe LU
- Sebastian Albinsson LU
- Bengt Uvelius LU
- opponent
-
- professor Falsig Pedersen, Stine Helene, Department of Biology, University of Copenhagen
- organization
- publishing date
- 2023
- type
- Thesis
- publication status
- published
- subject
- keywords
- Alternative splicing, Contractility, Inflammation, Muscarinic receptor, Myocardin-related transcription factors, Phenotypic modulation, Smooth muscle, SRF, WWTR1, YAP1
- in
- Lund University, Faculty of Medicine Doctoral Dissertation Series
- issue
- 2023:106
- pages
- 88 pages
- publisher
- Lund University, Faculty of Medicine
- defense location
- Segerfalksalen, BMC A10, Sölvegatan 17 i Lund
- defense date
- 2023-09-28 09:15:00
- ISSN
- 1652-8220
- ISBN
- 978-91-8021-447-6
- language
- English
- LU publication?
- yes
- id
- 16288e5b-36fa-4770-8683-0b56c4298309
- date added to LUP
- 2023-09-01 16:31:36
- date last changed
- 2025-04-04 14:45:19
@phdthesis{16288e5b-36fa-4770-8683-0b56c4298309, abstract = {{Smooth muscle cells (SMCs) are constituents of hollow inner organs. Their contractile function governs essential physiological functions, such as breathing, eating, blood pressure control, urination, and childbirth. Skeletal and cardiac muscle cells are terminally differentiated cell types, but SMCs are highly plastic and change their phenotype in disease. Cues presented by the microenvironment and altered biomechanics result in phenotypic conversions of SMCs. In the classical paradigm, SMCs are considered to switch from a contractile phenotype to a synthetic phenotype in response to changes in the microenvironment. Myocardin and two closely related transcription factors (MRTF-A and MRTF-B) play an important role in controlling SMC phenotype, and myocardin is essential for differentiation of SMCs during development. MRTFs form a ternary complex with serum response factor (SRF) on so called CArG boxes located in promoters and introns of thousands of genes. This thesis aims to provide new insights into the transcriptional regulation of and by myocardin-related transcription factors in SMCs. <br/>In my first study, I identified a previously undescribed transcriptional target of the MRTFs, namely the muscarinic M3 receptor, CHRM3. CHRM3 was activated by all MRTFs, but it was particularly forcefully regulated by MRTF-B. Knockout of SRF resulted in reduced CHRM3 expression in the urinary bladder and in the intestinal tract. In another study, I show that MRTFs cause cell type-dependent suppression of inflammation. This occurs partly through RelA titration and inhibition of NF-κB signaling. Hence, phenotypic modulation of SMCs involves toggling between contractile and inflammatory phenotypes, in addition to the classical switching between contractile and synthetic phenotypes. In a third study, I demonstrate that myocardin controls exon usage and splicing in SMCs and that this is mediated in part by RBPMS and RBFOX2. Among the splicing targets is myocardin itself, which may allow for slow and splicing-dependent SMC maturation. Finally, by studying mice with conditional and SMC-specific knockout of YAP and TAZ, I demonstrate reduction of myocardin expression in the urinary bladder. This has consequences for contractile differentiation, expression of muscarinic receptors, gene splicing, and contractility of bladder SMCs.<br/>In summary, new insight into transcriptional regulation of and by MRTFs in SMCs is provided by the papers in this thesis. This insight has stimulated ideas for treating disease and reducing side effects of available therapies.}}, author = {{Liu, Li}}, isbn = {{978-91-8021-447-6}}, issn = {{1652-8220}}, keywords = {{Alternative splicing; Contractility; Inflammation; Muscarinic receptor; Myocardin-related transcription factors; Phenotypic modulation; Smooth muscle; SRF; WWTR1; YAP1}}, language = {{eng}}, number = {{2023:106}}, publisher = {{Lund University, Faculty of Medicine}}, school = {{Lund University}}, series = {{Lund University, Faculty of Medicine Doctoral Dissertation Series}}, title = {{New insight into myocardin regulation and function in smooth muscle cells}}, year = {{2023}}, }